Phase 1/2 Study Of Investigational Hypoida-Targeted Drug, Th-302, And Bevacizumab (Hey) In Recurrent Glioblastoma (Gbm) Following Bey Failure
JOURNAL OF CLINICAL ONCOLOGY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2014)